Endothelium structure and function in kidney health and disease
- PMID: 30607032
- DOI: 10.1038/s41581-018-0098-z
Endothelium structure and function in kidney health and disease
Abstract
The kidney harbours different types of endothelia, each with specific structural and functional characteristics. The glomerular endothelium, which is highly fenestrated and covered by a rich glycocalyx, participates in the sieving properties of the glomerular filtration barrier and in the maintenance of podocyte structure. The microvascular endothelium in peritubular capillaries, which is also fenestrated, transports reabsorbed components and participates in epithelial cell function. The endothelium of large and small vessels supports the renal vasculature. These renal endothelia are protected by regulators of thrombosis, inflammation and complement, but endothelial injury (for example, induced by toxins, antibodies, immune cells or inflammatory cytokines) or defects in factors that provide endothelial protection (for example, regulators of complement or angiogenesis) can lead to acute or chronic renal injury. Moreover, renal endothelial cells can transition towards a mesenchymal phenotype, favouring renal fibrosis and the development of chronic kidney disease. Thus, the renal endothelium is both a target and a driver of kidney and systemic cardiovascular complications. Emerging therapeutic strategies that target the renal endothelium may lead to improved outcomes for both rare and common renal diseases.
Similar articles
-
A microscopic view on the renal endothelial glycocalyx.Am J Physiol Renal Physiol. 2015 May 1;308(9):F956-66. doi: 10.1152/ajprenal.00532.2014. Epub 2015 Feb 11. Am J Physiol Renal Physiol. 2015. PMID: 25673809 Review.
-
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway.Nephrol Dial Transplant. 2014 Apr;29(4):799-808. doi: 10.1093/ndt/gft516. Epub 2014 Jan 23. Nephrol Dial Transplant. 2014. PMID: 24463188
-
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.Am J Kidney Dis. 2001 Mar;37(3):601-11. doi: 10.1053/ajkd.2001.22087. Am J Kidney Dis. 2001. PMID: 11228186
-
Glomerular Endothelium and its Impact on Glomerular Filtration Barrier in Diabetes: Are the Gaps Still Illusive?Curr Med Chem. 2018;25(13):1525-1529. doi: 10.2174/0929867324666170705124647. Curr Med Chem. 2018. PMID: 28685678 Review.
-
Proteinuria: detection and role in native renal disease progression.Transplant Rev (Orlando). 2012 Jan;26(1):3-13. doi: 10.1016/j.trre.2011.10.002. Transplant Rev (Orlando). 2012. PMID: 22137726 Review.
Cited by
-
VEPTP inhibition with an extracellular domain targeting antibody did not restore albuminuria in a mouse model of diabetic kidney disease.Physiol Rep. 2024 Sep;12(18):e70058. doi: 10.14814/phy2.70058. Physiol Rep. 2024. PMID: 39324545 Free PMC article.
-
Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice.J Clin Invest. 2024 Aug 15;134(17):e174722. doi: 10.1172/JCI174722. J Clin Invest. 2024. PMID: 39225099 Free PMC article.
-
Association between lipoprotein-associated phospholipase A2 and 25-hydroxy-vitamin D on early stage diabetic kidney disease in patients with type-2 diabetes mellitus.Heliyon. 2024 Aug 6;10(16):e35635. doi: 10.1016/j.heliyon.2024.e35635. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39220926 Free PMC article.
-
Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets.Int J Mol Sci. 2024 Aug 20;25(16):9035. doi: 10.3390/ijms25169035. Int J Mol Sci. 2024. PMID: 39201721 Free PMC article. Review.
-
The Impairment of Endothelial Autophagy Accelerates Renal Senescence by Ferroptosis and NLRP3 Inflammasome Signaling Pathways with the Disruption of Endothelial Barrier.Antioxidants (Basel). 2024 Jul 23;13(8):886. doi: 10.3390/antiox13080886. Antioxidants (Basel). 2024. PMID: 39199133 Free PMC article.
References
-
- Verma, S. K. & Molitoris, B. A. Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin. Nephrol. 35, 96–107 (2015). - PubMed
-
- Roumenina, L. T., Rayes, J., Frimat, M. & Fremeaux-Bacchi, V. Endothelial cells: source, barrier, and target of defensive mediators. Immunol. Rev. 274, 307–329 (2016). - PubMed
-
- Jourde-Chiche, N., Dou, L., Cerini, C., Dignat-George, F. & Brunet, P. Vascular incompetence in dialysis patients—protein-bound uremic toxins and endothelial dysfunction. Semin. Dial. 24, 327–337 (2011). - PubMed
-
- Zoccali, C. et al. The systemic nature of CKD. Nat. Rev. Nephrol. 13, 344–358 (2017). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical